DK438288D0 - HYBRID PICORNAVIRUS AND METHOD FOR PRODUCING THERE AND VACCINE BASED ON SUCH A VIRUS - Google Patents

HYBRID PICORNAVIRUS AND METHOD FOR PRODUCING THERE AND VACCINE BASED ON SUCH A VIRUS

Info

Publication number
DK438288D0
DK438288D0 DK438288A DK438288A DK438288D0 DK 438288 D0 DK438288 D0 DK 438288D0 DK 438288 A DK438288 A DK 438288A DK 438288 A DK438288 A DK 438288A DK 438288 D0 DK438288 D0 DK 438288D0
Authority
DK
Denmark
Prior art keywords
virus
producing
vaccine based
picornavirus
hybrid
Prior art date
Application number
DK438288A
Other languages
Danish (da)
Other versions
DK438288A (en
Inventor
Marc Girard
Cyslaw Wychowski
Annette Martin
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of DK438288D0 publication Critical patent/DK438288D0/en
Publication of DK438288A publication Critical patent/DK438288A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK438288A 1987-08-07 1988-08-05 HYBRID PICORNAVIRUS AND METHOD FOR PRODUCING THERE AND VACCINE BASED ON SUCH A VIRUS DK438288A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711337A FR2619012B1 (en) 1987-08-07 1987-08-07 VACCINES IN WHICH THE CHARACTERISTIC EPITOPE IS INCORPORATED IN A PROTEIN OF PICORNAVIRUS, ESPECIALLY POLIOVIRUS

Publications (2)

Publication Number Publication Date
DK438288D0 true DK438288D0 (en) 1988-08-05
DK438288A DK438288A (en) 1989-04-10

Family

ID=9354047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK438288A DK438288A (en) 1987-08-07 1988-08-05 HYBRID PICORNAVIRUS AND METHOD FOR PRODUCING THERE AND VACCINE BASED ON SUCH A VIRUS

Country Status (11)

Country Link
EP (1) EP0302801B1 (en)
JP (1) JPH01157380A (en)
AR (1) AR242057A1 (en)
AT (1) ATE129288T1 (en)
DE (1) DE3854591D1 (en)
DK (1) DK438288A (en)
FR (1) FR2619012B1 (en)
OA (1) OA08749A (en)
PT (1) PT88219B (en)
WO (1) WO1989001516A1 (en)
ZA (1) ZA885774B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) * 1988-06-10 1998-05-05 Therion Biologics Corporation Self-assembled, defective, non-self-propagating lentivirus particles
JPH04502760A (en) * 1988-10-03 1992-05-21 レプリゲン・コーポレーション Novel HIV proteins and peptides effective in the diagnosis, prevention and treatment of AIDS
GB8912496D0 (en) * 1989-05-31 1989-07-19 Medical Res Council Vaccines
EP0478588A1 (en) * 1989-05-31 1992-04-08 Medical Research Council Poliovirus chimaeras
CA2033175C (en) * 1989-06-01 2005-01-11 Gail P. Mazzara Self-assembled, defective, non-self-propagating viral particles
US5817491A (en) * 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
ATE188740T1 (en) * 1991-02-19 2000-01-15 Univ California VIRUS PARTICLES WITH ALTERED HOST SPECTRUM
GB9125896D0 (en) * 1991-12-05 1992-02-05 Almond Jeffrey W Bicistronic viruses
CA2164297A1 (en) * 1993-06-03 1994-12-22 Ralf Altmeyer Mengovirus as a vector for expression of foreign polypeptides
US6071742A (en) 1997-03-05 2000-06-06 Board Of Regents Of The University Of Nebraska Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
WO2000014263A2 (en) * 1998-09-03 2000-03-16 Board Of Regents, The University Of Texas System Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
JP4753943B2 (en) 2004-07-13 2011-08-24 ジェン−プローブ・インコーポレーテッド Compositions and methods for detection of hepatitis A virus nucleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins

Also Published As

Publication number Publication date
FR2619012A1 (en) 1989-02-10
EP0302801A1 (en) 1989-02-08
DE3854591D1 (en) 1995-11-23
ZA885774B (en) 1989-04-26
ATE129288T1 (en) 1995-11-15
PT88219B (en) 1995-09-12
PT88219A (en) 1989-06-30
EP0302801B1 (en) 1995-10-18
OA08749A (en) 1989-03-31
AR242057A1 (en) 1993-02-26
FR2619012B1 (en) 1989-12-22
WO1989001516A1 (en) 1989-02-23
DK438288A (en) 1989-04-10
JPH01157380A (en) 1989-06-20

Similar Documents

Publication Publication Date Title
DK438288D0 (en) HYBRID PICORNAVIRUS AND METHOD FOR PRODUCING THERE AND VACCINE BASED ON SUCH A VIRUS
DK581789A (en) METHOD FOR RECOVERING ETHAN
DK522989D0 (en) PROCEDURE FOR OPERATING A COOLING SYSTEM AND COOLING SYSTEM FOR EXERCISING THE PROCEDURE
DK390A (en) METHOD FOR PREPARING HYDROXYLAPATITE
DK149589D0 (en) DNA SEQUENCE, DNA VECTOR, MUTERATED HIV VIRUS THROUGH, HIV VACCINE AND METHOD FOR PRODUCING SAME
DE3867029D1 (en) METHOD FOR PRODUCING AETHYLENE COPOLYMERS.
DE68907258D1 (en) METHOD FOR PRODUCING PERFLUORED COPOLYMERS.
DE3877730D1 (en) METHOD FOR PRODUCING ACRYLNITRILE.
DK234590A (en) METHOD FOR TREATING RETROVIRUS INFECTIONS
DE3769608D1 (en) METHOD FOR PREPARING HEAT-RESISTANT COLOPHONIUM ESTERS.
DK126489A (en) PROCEDURE FOR PREPARING A PIPE
DK503488A (en) PROCEDURE FOR PREPARING POLYMERS
DE3777024D1 (en) METHOD AND DEVICE FOR RELEASING A MAGNETIC HEAD.
DK161788D0 (en) PROCEDURE FOR PREPARING ZIDOVUDIN
ZA894182B (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
DK14589A (en) METHOD OF PREPARING 1-ALKYL-5-NITROIMIDAZOLES
DK39789A (en) PROCEDURE FOR PREPARING N-PHOSPHONMETHYLIMINODYDIC ACID
DK3588D0 (en) PROCEDURE FOR PREPARING A PLASTICS
DE3883271D1 (en) METHOD FOR PRODUCING AETHYLENE COPOLYMERS.
DK39689D0 (en) METHOD FOR PREPARING N-PHOSPHONMETHYLIMINODYDIC ACID AND N-PHOSPHONMETHYLIMINODYDICYCHLORIDE
DK471588D0 (en) METHOD OF PREPARING POLYMERS
DK0451452T3 (en) Recombinant plasmid for lipase expression and method for producing a lipase
DK358288A (en) METHOD FOR PREPARING 2-ARYLTHIOBENOIC ACIDS
DE68900946D1 (en) METHOD FOR PRODUCING ACRYLNITRILE.
FI885796A0 (en) A method for stabilizing a polymerized rosin resin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment